Detalhe da pesquisa
1.
Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae.
Eur J Clin Microbiol Infect Dis
; 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376634
2.
Hepatitis B Virus-Hepatitis D Virus mother-to-child co-transmission: A retrospective study in a developed country.
Liver Int
; 38(4): 611-618, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28834623
3.
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience.
Infect Dis Ther
; 12(1): 257-271, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441485
4.
Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up.
J Clin Virol
; 85: 86-89, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27865174
5.
Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets.
PLoS One
; 10(10): e0140435, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474181
6.
The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients.
AIDS
; 28(2): 278-81, 2014 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24361684
7.
Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients.
PLoS One
; 7(6): e37032, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22715361
8.
Reply to Immunometabolism may provide insights into novel mechanisms of HIV reservoir persistence.
AIDS
; 30(18): 2896-2898, 2016 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27824629
9.
Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: maraviroc, raltegravir, etravirine.
J Acquir Immune Defic Syndr
; 56(4): e113-5, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21350358